Brain Evolve
Brain Evolve, licence 80070075: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Brain Dream, Brain Evolve PM Formula Tropical Blend, Brain Evolve PM Formula Unflavoured
- Licence holder
- GCO PACKAGING AND MANUFACTURING LTD. dba HAVN LIFE RETAIL
- NPN or DIN-HM
- 80070075
- Status
- Active licence
- Licence date
- 8 June 2016
- Revision date
- 16 November 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1.0 Dry plant equivalent : 5000 milligramme Potency : 24.0 % Flavonoid glycosides | 100.0 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
| Phosphatidylsérine Source : Phosphatidylserine | 120.0 milligramme | Not calculated |
| Phosphatidylsérine Source : Helianthus annuus - Graine | 120.0 milligramme | Not calculated |
| Phosphatidylcholine Source : Glycine max - Graine | 60.0 milligramme | Not calculated |
| Phosphatidylcholine Source : Phosphatidylcholine (from Glycine max) | 60.0 milligramme | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine | 269.0 milligramme | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Camellia sinensis - feuille | 269.0 milligramme | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 2.0 milligramme | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 2.0 milligramme | Not calculated |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Acide R-alpha lipoïque | 400.0 milligramme | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 500.0 milligramme | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 500.0 milligramme | Not calculated |
| L-Glutamine Source : Medicago sativa - graine | 3000.0 milligramme | Not calculated |
| L-Glutamine Source : Acide glutamique | 3000.0 milligramme | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 657.0 milligramme | Not calculated |
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : Ribose | 600.0 milligramme | Not calculated |
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 495.0 milligramme | Not calculated |
| 3,4,5-Acide trihydroxybenzoïque, (2R, 3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphényl)-2H-1-benzopyrane-3-yl ester Source : Groupe de Phospholipides de Poly(phénols) de thé vert - feuille | 200.0 milligramme | Not calculated |
| 3,4,5-Acide trihydroxybenzoïque, (2R, 3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphényl)-2H-1-benzopyrane-3-yl ester Source : 3-gallate d'épigallocatéchine | 200.0 milligramme | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 2.0 milligramme | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Animaux autre que l'humain non susceptibles à l' EST - Corps pinéal | 2.0 milligramme | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcumine | 380.0 milligramme | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - Racine | 380.0 milligramme | Not calculated |
| Acide aminoacétique Source : Glycine | 500.0 milligramme | Not calculated |
| Acide aminoacétique Source : Glycine max - Graine | 500.0 milligramme | Not calculated |
Non-medicinal ingredients
Saveur d'orange, Stevia leaf extract, Tropical Punch Flavour, Saveur de mangue, Saveur de papaye, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Provides antioxidants for the maintenance of good health. Source of antioxidants. Source of antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of carbohydrates to support energy production. Source of amino acid involved in muscle protein synthesis. Helps to enhance cognitive function and memory in adults. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps to prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people travelling by plane easterly across two or more time zones/if flying east over two or more time zones). Helps to speed up/ reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase. Helps to re-set the body's sleep-wake cycle (aspect of the circadian rhythm).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070075
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.